InvestorsHub Logo
Followers 800
Posts 50868
Boards Moderated 2
Alias Born 12/12/2004

Re: None

Tuesday, 10/14/2014 8:41:47 AM

Tuesday, October 14, 2014 8:41:47 AM

Post# of 49606
SAN DIEGO, Oct. 14, 2014 /PRNewswire/ -- Aethlon Medical, Inc. (NASDAQ:OTCQB:AEMD), announced today the first use of Hemopurifier® therapy on a patient infected with Ebola virus. The treatment was administered to a Ugandan doctor at the Frankfurt University Hospital in Germany. The patient, who is also a World Health Organization (WHO) worker, contracted the virus in Sierra Leone.

DUKE BASKETBALL and NOTRE DAME FOOTBALL

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.